[HTML][HTML] Drug-induced oxidative stress in cancer treatments: Angel or devil?

H Jiang, J Zuo, B Li, R Chen, K Luo, X Xiang, S Lu… - Redox Biology, 2023 - Elsevier
Oxidative stress (OS), defined as redox imbalance in favor of oxidant burden, is one of the
most significant biological events in cancer progression. Cancer cells generally represent a …

Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression

FL Sarmiento-Salinas, A Perez-Gonzalez… - Life Sciences, 2021 - Elsevier
Cancer is one of the major causes of death in the world and its global burden is expected to
continue increasing. In several types of cancers, reactive oxygen species (ROS) have been …

Molecular mechanisms and clinical implications of the gold drug auranofin

S Shen, J Shen, Z Luo, F Wang, J Min - Coordination Chemistry Reviews, 2023 - Elsevier
Auranofin (AUR) is an orally available lipophilic gold-based anti-inflammatory compound
used for the treatment of rheumatoid arthritis (RA). Recent evidence indicates that AUR may …

The gold complex auranofin: new perspectives for cancer therapy

FH Abdalbari, CM Telleria - Discover Oncology, 2021 - Springer
Advanced stages of cancer are highly associated with short overall survival in patients due
to the lack of long-term treatment options following the standard form of care. New options …

[HTML][HTML] Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell …

LF Boullosa, J Van Loenhout, T Flieswasser… - Redox biology, 2021 - Elsevier
Auranofin (AF) is an FDA-approved antirheumatic drug with anticancer properties that acts
as a thioredoxin reductase 1 (TrxR) inhibitor. The exact mechanisms through which AF …

Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness

T Gamberi, G Chiappetta, T Fiaschi… - Medicinal Research …, 2022 - Wiley Online Library
Auranofin is an oral gold (I) compound, initially developed for the treatment of rheumatoid
arthritis. Currently, Auranofin is under investigation for oncological application within a drug …

[HTML][HTML] Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases

R Gencheva, Q Cheng, ESJ Arner - Free Radical Biology and Medicine, 2022 - Elsevier
Human thioredoxin reductase (TrxR) is a selenoprotein with a central role in cellular redox
homeostasis, utilizing a highly reactive and solvent-exposed selenocysteine (Sec) residue in …

Targeting neuroinflammation in brain cancer: uncovering mechanisms, pharmacological targets, and neuropharmaceutical developments

MS Alghamri, BL McClellan, CS Hartlage… - Frontiers in …, 2021 - frontiersin.org
Gliomas are one of the most lethal types of cancers accounting for∼ 80% of all central
nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the …

[HTML][HTML] The potential role of vitamin C in empowering cancer immunotherapy

T Bedhiafi, VP Inchakalody, Q Fernandes… - Biomedicine & …, 2022 - Elsevier
Vitamin C also known as L-ascorbic acid is a nutrient naturally occurring in many fruits and
vegetables and widely known for its potent antioxidant activity. Several studies have …

Natural molecules targeting thioredoxin system and their therapeutic potential

J Zhang, D Duan, A Osama, J Fang - Antioxidants & Redox …, 2021 - liebertpub.com
Significance: Thioredoxin (Trx) and thioredoxin reductase are two core members of the Trx
system. The system bridges the gap between the universal reducing equivalent NADPH and …